aTyr Pharma, Inc. (ATYR) Dividend History

aTyr Pharma, Inc. is a biotechnology company focused on developing innovative therapies targeting rare and severe diseases, particularly those involving neuroinflammation and immune modulation. The company's approach involves designing molecules that can restore or maintain healthy cellular functions, with an emphasis on the nervous and immune systems.

10240 Sorrento Valley Road, San Diego, CA, 92121
Phone: (858) 731-8389
Website: https://www.atyrpharma.com

Dividend History

aTyr Pharma, Inc. currently does not pay dividends

Company News

aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis

aTyr Pharma announced that it will present research on its tRNA synthetase candidate ATYR0101, which has shown anti-fibrotic effects in preclinical models of lung and kidney fibrosis. The findings suggest ATYR0101 has the potential to be a novel and differentiated anti-fibrotic therapeutic.

GlobeNewswire Inc.
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 - GlobeNewswire

aTyr Pharma has completed enrollment in its global Phase 3 study of efzofitimod for the treatment of pulmonary sarcoidosis, a rare lung disease. The study enrolled 268 patients, exceeding the target, and topline data are expected in Q3 2025.

GlobeNewswire Inc.
Is aTyr Pharma (ATYR) Outperforming Other Medical Stocks This Year?

Here is how Atyr Pharma (ATYR) and High Tide Inc. (HITI) have performed compared to their sector so far this year.

Zacks Investment Research

Featured Companies: HITI

Dividend data last updated 06/08/2025 00:03:53 UTC